Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cadherin 17 (CDH17) is a calcium-dependent cell adhesion molecule and intestinal proton-dependent peptide transporter primarily expressed in the gastrointestinal tract and pancreatic ducts. It plays a crucial role in tissue structure and morphogenesis. Aberrant expression is observed in several gastrointestinal malignancies, including hepatocellular carcinoma, stomach cancer, colorectal cancer, and pancreatic cancer, making it an attractive therapeutic target.
Inhibition of CDH17 can inhibit tumor growth, suppress Wnt signaling pathway activity, and activate tumor suppressor genes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cadherin 17 (CDH17).